Metopio
Metopio is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Metopio.
Metopio is a company.
Key people at Metopio.
Metopio is a Chicago-based SaaS company founded in 2019 that builds a community intelligence platform providing instant access to thousands of U.S. datasets, AI-powered analytics, and automated report generation for community health needs assessments (CHNAs) and improvement plans (CHIPs).[1][2][3][4] It serves over 475 hospitals, public health departments, and community organizations covering more than 20 million people, solving the problem of data silos and manual analysis that hinder timely health interventions by simplifying workflows and enabling data-driven decisions regardless of user expertise.[1][2][3][4] With $7M raised including a recent multi-million-dollar growth round led by Plymouth Growth in April 2025, Metopio demonstrates strong momentum, funding product expansion, team growth, and enhanced support amid rising demand for actionable health data.[1][2][3]
Metopio was founded in 2019 in Chicago by CEO and Co-Founder Will Snyder, COO and Co-Founder Angie Grover, and CTO and Co-Founder Jonathan Giuffrida, alongside key executives like CRO Rich Baker, VP of Data Heather Blonsky, Principal Engineer Jason Skicewicz, and VP of Marketing Erin Giegling.[2][4] The idea emerged from years of collaboration with public health and healthcare leaders frustrated by complex, outdated data systems that slowed decision-making, prompting the team to build a platform that makes data "easy, insightful, and actually useful."[4] Early traction built on this listening approach, evolving into a trusted solution now used by hundreds of organizations, with pivotal growth via its Series A stage and the 2025 Plymouth Growth investment marking a scaling milestone.[1][2][3]
Metopio rides the wave of AI-driven health data democratization and precision public health, capitalizing on post-pandemic urgency for community-level insights amid rising chronic disease burdens and SDOH focus.[1][3][4] Timing aligns with regulatory mandates for CHNAs/CHIPs and healthcare's shift to value-based care, where data silos cost efficiency—Metopio's platform accelerates responses with "unprecedented speed and precision."[1][3] Market tailwinds include B2B SaaS growth in mid-continent tech (per investor Plymouth Growth) and AI adoption in nonprofits/health systems, positioning Metopio to influence ecosystems by enabling scalable interventions and collaborations that boost outcomes.[1][2][3]
Metopio's fresh growth capital positions it for rapid expansion, likely enhancing AI features, dataset depth, and user support to capture more of the $100B+ U.S. public health tech market.[1][2] Trends like federated data sharing, predictive analytics for epidemics, and ESG-driven grants will propel it, evolving its role from assessment tool to full community health OS. As CEO Will Snyder notes, every dataset ties to "real lives," suggesting deepening ecosystem influence through partnerships—watch for national rollout and outcome benchmarks tying platform use to measurable health gains, amplifying its transformative edge in data-empowered care.[3] This builds on its core promise: turning overwhelming data into life-improving action.[1][4]
Key people at Metopio.
